News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Pharmacology and learn more about our faculty’s latest achievements, awards and honors.
- 03.15.2018Q&A with Brittany Hopkins, a fourth-year student in the Northwestern University Interdepartmental Neuroscience (NUIN) program, studying in laboratory of Richard J. Miller, PhD, the Alfred Newton Richards Professor of Pharmacology.
Investigators found two genes that modulate the severity of Long QT Syndrome, an inherited cardiac disorder that can cause heart arrhythmias and sudden death.
A new Northwestern Medicine study detailed a technique that could help scientists find the cause of cancer or autism-spectrum disease stemming from faulty protein disposal.
Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.
Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
- 08.31.2017Glenn Ellis is a Health and Wellness Educator and Writer, whose work centers around Health Equity and Ethics in Medicine. On this episode of Strategies for Wellbeing, Minoli Perera, Minoli Perera, PharmD, PhD, discusses her groundbreaking work using a patient's genome to predict drug response in minority populations.
A new study explains how mutations in a sodium channel can lead to a disorder causing insensitivity to pain.
Northwestern Medicine scientists have mapped the complete structure of a voltage-gated sodium channel, proteins in the membrane of cells that play an important role in many diseases.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
Northwestern Medicine scientists identified the process by which a calcium channel called the CRAC channel opens and closes, and how mutations in the channel structures that control its opening cause disease.
Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
Former and current colleagues, students and friends gathered to celebrated the career of Paula Stern, PhD, an authority on bone and mineral health research, and a respected leader and educator.
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.
A new study shows potential mechanisms leading to the activation of a mutated gene in autosomal dominant polycystic kidney disease.
Northwestern Medicine scientists co-authored a study that identified a blood cell not normally found in the healthy brain that can invade brain tissue after status epilepticus, a type of seizure, and contributes to inflammation.
Northwestern Medicine scientists have received a $7.5 million grant to study how genetic information from African American patients can predict their responses to medications.
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
A trail of messenger molecules left behind by general immune system cells called neutrophils helps virus-specific T-cells reach tissues infected by influenza, reports a new study published in Science.
Northwestern Medicine scientists received a five-year, $3.9 million grant from the National Institutes of Health to determine the optimal drug doses for treating pregnant women with depression.
Northwestern Medicine scientist Jeffrey Savas, PhD, and colleagues identified a receptor that sorts proteins in synapses, a finding that may augment future treatments for multiple neurological diseases and disorders.
Northwestern Medicine scientists investigated the mechanism behind a mutation in a calcium ion channel that leads to an immunodeficiency syndrome.
Northwestern Medicine scientists, inspired by treatments used by traditional healers in Nigeria, have synthesized four new chemical compounds that may lead to therapies for psychiatric disorders.
Male baldness clinical trials did not adequately report sexual dysfunction, which may persist long-term, according to a Northwestern Medicine meta-analysis of published reports of clinical trials of the drug finasteride.
A new Northwestern Medicine study published in the New England Journal of Medicine shows the drug Eylea is superior to other options for improving the eyesight of persons with poor vision due to diabetic macular edema, a major cause of diabetes-related vision loss.